New York State Common Retirement Fund Raises Holdings in Cognex Corporation $CGNX

New York State Common Retirement Fund lifted its position in Cognex Corporation (NASDAQ:CGNX) by 3.0% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 737,531 shares of the scientific and technical instruments company’s stock after purchasing an additional 21,566 shares during the quarter. New York State Common Retirement Fund owned approximately 0.44% of Cognex worth $23,394,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. TD Waterhouse Canada Inc. acquired a new stake in shares of Cognex in the second quarter valued at approximately $29,000. Penserra Capital Management LLC acquired a new stake in Cognex during the 2nd quarter worth $29,000. Geneos Wealth Management Inc. grew its position in Cognex by 402.2% during the 1st quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock worth $27,000 after purchasing an additional 736 shares during the last quarter. MassMutual Private Wealth & Trust FSB increased its stake in Cognex by 231.9% in the second quarter. MassMutual Private Wealth & Trust FSB now owns 1,082 shares of the scientific and technical instruments company’s stock valued at $34,000 after purchasing an additional 756 shares during the period. Finally, Farther Finance Advisors LLC raised its holdings in shares of Cognex by 31.5% in the second quarter. Farther Finance Advisors LLC now owns 1,277 shares of the scientific and technical instruments company’s stock valued at $40,000 after buying an additional 306 shares during the last quarter. Institutional investors and hedge funds own 88.12% of the company’s stock.

Cognex Price Performance

NASDAQ CGNX opened at $37.95 on Tuesday. The business has a 50 day moving average price of $42.53 and a 200 day moving average price of $38.69. The company has a market capitalization of $6.36 billion, a P/E ratio of 59.30 and a beta of 1.52. Cognex Corporation has a 1-year low of $22.67 and a 1-year high of $49.76.

Cognex (NASDAQ:CGNX) last released its quarterly earnings results on Wednesday, October 29th. The scientific and technical instruments company reported $0.33 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.06. The business had revenue of $264.00 million during the quarter, compared to the consensus estimate of $261.86 million. Cognex had a return on equity of 8.26% and a net margin of 11.33%.The business’s revenue was up 18.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.20 EPS. Cognex has set its Q4 2025 guidance at 0.190-0.24 EPS. On average, research analysts expect that Cognex Corporation will post 0.61 earnings per share for the current fiscal year.

Cognex Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 28th. Investors of record on Thursday, November 13th were given a dividend of $0.085 per share. The ex-dividend date was Thursday, November 13th. This represents a $0.34 annualized dividend and a dividend yield of 0.9%. This is an increase from Cognex’s previous quarterly dividend of $0.08. Cognex’s payout ratio is presently 53.13%.

Wall Street Analysts Forecast Growth

Several research firms have commented on CGNX. Barclays reaffirmed an “overweight” rating and set a $56.00 price objective (up from $55.00) on shares of Cognex in a research note on Friday, October 31st. DA Davidson set a $38.00 price objective on shares of Cognex and gave the company a “neutral” rating in a research note on Monday, November 3rd. UBS Group restated a “buy” rating and set a $58.00 price objective on shares of Cognex in a research report on Friday, October 31st. Robert W. Baird set a $45.00 price target on shares of Cognex in a research note on Friday, October 31st. Finally, JPMorgan Chase & Co. began coverage on shares of Cognex in a research report on Monday, September 15th. They issued a “neutral” rating and a $45.00 price objective for the company. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $46.20.

Insider Activity at Cognex

In related news, EVP Sheila Marie Dipalma sold 2,002 shares of the company’s stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $45.00, for a total value of $90,090.00. Following the sale, the executive vice president owned 8,582 shares of the company’s stock, valued at approximately $386,190. This represents a 18.92% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Robert Willett sold 6,704 shares of the stock in a transaction on Tuesday, October 21st. The shares were sold at an average price of $49.51, for a total value of $331,915.04. The SEC filing for this sale provides additional information. Insiders have sold a total of 10,706 shares of company stock valued at $512,065 over the last 90 days. Insiders own 1.60% of the company’s stock.

Cognex Profile

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.